ArticleStem cell research & therapy2021

Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling.

Nari Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.